| | Gout | | | Hyperuricemia and Gout: An Overview of Practice Management and Emerging Therapies
Overview
Is hyperuricemia another door to the metabolic syndrome? This activity will focus on hyperuricemia and gout and will examine the latest guidance around treating patients in the primary care practice. The program will include a focus on the latest guidelines as well as applying the learning into everyday practice dynamics.
Objectives
List the key components of a differential diagnosis for gout based on clinical history and physical examination elements
Develop a treatment plan, which includes behavioral modification and pharmacologic strategies
Faculty
Robert A. Terkeltaub, MD
Chief of Rheumatology
Veterans Administration Medical Center
Professor of Medicine and Associate Division Director
University of California, San Diego
San Diego, CA
Joseph A. Lieberman III, MD, MPH
Professor of Family Medicine
Jefferson Medical College
Thomas Jefferson University
Associate Editor, Delaware Medical Journal
Philadelphia, PA
| | | PAD | | | Prevent the Event:Early Detection and Management of the PAD Patient
Overview
PAD is frequently unrecognized and many patients at risk are currently not identified and treated. Current estimates are that 8-12 million Americans have PAD, with the highest incidence among those over 70 years of age, regardless of health status, and people over 50 years of age with diabetes mellitus.
This lecture will overview the tremendous risk associated with PAD, discuss the major risk factors for developing PAD, and highlight the role of primary care in detecting and diagnosing the condition through increased use of ABI screening. Current therapies will be discussed including symptom improvement and prevention of future CV events with an emphasis on patient compliance issues.
Objectives
Identify the risk factors for those patients most at risk for PAD and therefore should be screened utilizing ABI
Name the 2 goals of management of PAD
Faculty
Richard V. Milani, MD, FACC, FAHA
Vice-Chairman, Department of Cardiology
Ochsner Clinic Foundation
New Orleans, LA
Philip Altus, MD, MACP
Professor Emeritus, Department of Medicine
University of South Florida
Tampa, FL
| | | Pain Management | | | Management of Patients with Refractory Chronic Low Back Pain in the Primary Care Setting
Overview
Patients with refractory chronic low back pain represent a clinical challenge to primary care practitioners. Worsening persistent pain, an array of comorbid conditions, and loss of function coupled with a lack of evidence for treatment can create a clinical conundrum. Learn how to improve the longitudinal management of patients presenting to your practice with this ubiquitous and demanding condition.
Objectives
Select validated tools for use in comprehensive assessment and risk-stratification of patients with refractory chronic low back pain treated with opioids
Devise a treatment plan specific to the needs of chronic low back pain patients that demonstrate an understanding of recommended guidelines published jointly by the ACP/APS
Faculty
Michael Brennan, MD
Bill McCarberg, MD
Adjunct Assistant Clinical Professor
University of California
San Diego, CA
| | | Diabetes Spotlight | | | Spotlight on Diabetes: Managing Patients in Primary Care
Overview
Leading clinicians will offer an interactive, case-based approach to the diagnosis and treatment of patients with pre-diabetes and diabetes to review the best methods to prevent disease onset and optimal treatment regimens to manage progression.
Objectives
Define pre-diabetes and monitor its development through the measurement of impaired fasting glucose (IFG) or impaired glucose tolerance (IGT)
Identify CVD risk factors in diabetic patients and be familiar with therapeutic goals and treatment strategies for dyslipidemia, hypertension, metabolic syndrome and obesity
Identify how ethnicity plays a role in CVD risk stratification
Identify strategies for the treatment of the diabetic patient with obesity including lifestyle changes, therapeutic strategies and surgical interventions
Devise a strategy for the use of insulin in the primary care practice, including short-acting and long-acting analogues, combination therapy and delivery devices
Describe incretin biology and current and emerging incretin therapeutics, including combination therapy, in the treatment of type 2 diabetes and explain the side effects of medication, which will improve patient compliance
Faculty
Frank Lavernia, MD
Internal Medicine and Diabetes
Founder, North Broward Diabetes Center
Coconut Creek, FL
Ken Fujioka, MD
Director of Nutrition and Metabolic Research
Department of Diabetes and Endocrine
Scripps Clinic
San Diego, CA
Lawrence Blonde, MD, FACP, FACE
Director, Ochsner Diabetes Clinical Research Unit Ochsner Clinic Foundation Dept. of Endocrinology, Diabetes and Metabolic Diseases
New Orleans, LA
Thomas M. Flood, MD, FACE
Georgia Center for Diabetes
Atlanta, GA
| | | Dyslipidemia | | | Early and Aggressive LDL-C Management: Perspectives on Commonly Asked Questions
Overview
This presentation will address early and aggressive LDL-C management and the clinical challenges of goal attainment. Clinicians will be provided with pathways and knowledge to help them improve their patient outcomes by goal attainment of the healthy lipid profile.
Discussion will be applicable to clinicians' practice including lifestyle changes of diet and exercise, along with pharmacologic treatment options available for lipid management in order to give the appropriate tools to get patients to their true LDL goals.
Objectives
Understand the key tenets of assessing and managing dyslipidemia in clinical practice and the current evidence regarding the safety and efficacy of available LDL-C lowering therapies
Identify at least 2 lipid lowering strategies to initiate and tailor comprehensive management treatment plans for patients with high LDL-C in order to reach and maintain targeted goals
Faculty
Benjamin J. Ansell, MD
Ronald A. Codario, MD, FACP
Clinical Instructor in Medicine
Thomas Jefferson University Hospital
University of Pennsylvania Health System
Philadelphia, PA
| | | Helicobacter pylori Infection | | | The Challenges of Helicobacter pylori Infection: What You Need to Know about Evaluation and Eradication
Overview
Helicobacter pylori infection, which affects 20% of the US population and is associated with upper gastrointestinal conditions ranging from chronic gastritis to gastric malignancy, is an enigma to many clinicians without a large GI patient base. This program will increase participants' confidence and competency by: (1) providing the basics about H pylori evaluation, both pre- and post-treatment, along with techniques for integrating such evaluation into PCP practice, and (2) providing strategies for selecting appropriate treatment regimens for different clinical situations and for maximizing patient adherence.
Objectives
Identify patients in whom diagnostic testing for H pylori infection is indicated and determine the most appropriate tests for detecting infection, confirming eradication in specific situations as defined by guidelines
Identify the issues around H pylori treatment to communicate to patients including the complexity of and the rationale for the treatment plan
Faculty
| | | Smoking Cessation | | | Do Ask, Do Tell: Successful Smoking Interventions
Overview
Smoking is the single most important preventable cause of death in the United States. This session, "Do Ask, Do Tell: Successful Smoking Interventions", will address practical ways primary care clinicians can help their patients quit smoking.
Objectives
Screen all patients for smoking status and design individualized cessation interventions for patients who smoke
Commit to active follow-up with patients along the smoking cessation path
Faculty
Lesley A. Schroeder, MD
Associate Clinical Professor
Department of Psychiatry & Behavioral Sciences
University of CA-Davis
Sacramento, CA
| | | Fibromyalgia | | | New Developments in Diagnosis and Management of Fibromyalgia
Overview
This educational initiative will provide primary care practitioners insight regarding assessment of chronic musculoskeletal pain with a focus on fibromyalgia and common overlapping diagnoses. This program will also provide primary care practitioners with new information about evidenced based therapies used to manage fibromyalgia.
Objectives
Identify the differential diagnosis of chronic musculoskeletal pain and clinical characteristics that suggest a diagnosis of fibromyalgia
Identify evidence based treatment strategies for fibromyalgia including two nonpharmacologic and two pharmacologic strategies
Faculty
Rakesh Jain, MD, MPH
Director, Psychiatric Drug Research
R/D Clinical Research Center
Lake Jackson, TX
Neil Skolnik, MD
Professor of Family and Community Medicine
Temple University School of Medicine
Philadelphia, PA
|
|
